SNN Stock Summary and Trading Ideas (Smith & Nephew Snats | NYSE:SNN)

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Snats trades on the NYSE stock market under the symbol SNN.

As of October 23, 2026, SNN stock price declined to $30.83 with 1,280,773 million shares trading.

SNN has a beta of 0.36, meaning it tends to be less sensitive to market movements. SNN has a correlation of 0.04 to the broad based SPY ETF.

SNN has a market cap of $12.90 billion. This is considered a Large Cap stock.

In the last 3 years, SNN traded as high as $38.79 and as low as $21.53.

The top ETF exchange traded funds that SNN belongs to (by Net Assets): BINV, DFIC, AVDE, DFAX, APIE.

SNN has underperformed the market in the last year with a return of -14.9%, while SPY returned +14.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SNN shares. However, SNN has outperformed the market in the last 3 month and 2 week periods, returning +4.0% and +14.4%, while SPY returned +1.9% and -1.8%, respectively. This indicates SNN has been having a stronger performance recently.

SNN support price is $30.40 and resistance is $31.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNN shares will trade within this expected range on the day.